Echo IQ’s EchoSolv-AS decision-support software for cardiology, presented at the New York Valves scientific conference, uses artificial intelligence to improve identification of high-risk aortic stenosis. The software has been shown to be successful in identifying more patients at risk than human-only diagnosis.